MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    VPS35-Related Parkinson Disease in a Patient of Korean Ancestry: A Case Report

    B. Yasuda, M. Bruno (Honolulu, USA)

    Objective: To report a case of a 65-year-old Korean woman diagnosed with a rare gene mutation involving VPS35 linked to Parkinson’s disease (PD). Background: Major…
  • 2025 International Congress

    Genetic variants detection and prevalence in Hawaii’s diverse PD population

    M. Faouzi, K. Thai, R. Shuman, E. Krening, A. Yake, F. Gao, M. Bruno (Hawaii, USA)

    Objective: To overcome access barriers to genetic testing and address the paucity of knowledge regarding genetic causes of PD among Hawaii’s racial and ethnic groups.…
  • 2025 International Congress

    Unveiling Parkinson’s Disease Variants in the Chinese Population: The CPD10KGP Study

    Y. Zhao, Z. Liu, H. Pan, J. Guo, B. Tang (Changsha, China)

    Objective: In response to these limitations, we are proposing the China Parkinson’s Disease 10,000 Genomes Project (CPD10KGP), which aims to delineate the genetic architecture of…
  • 2025 International Congress

    Parameterization of Intraoperative Human Microelectrode Recordings: Linking Action Potential Morphology to Brain Anatomy

    M. Baker, B. Klassen, M. Jensen, G. Ojeda Valencia, H. Heydari, N. Ince, K. Müller, K. Miller (Rochester, USA)

    Objective: To investigate whether single-unit spike morphology from intraoperative microelectrode recordings (MER) can provide anatomical and physiological insights relevant to deep brain stimulation (DBS) targeting.…
  • 2025 International Congress

    Magnetic Resonance Guided Focused Ultrasound for Essential Tremor and Tremor dominant Parkinson’s Disease Case Series

    M. Jayasree, M. Panigrahi, G. Gorrepati (Hyderabad, India)

    Objective: To assess the efficacy and safety of Magnetic Resonance Guided Focused Ultrasound (MRgFUS) for Essential Tremor (ET) and Tremor Dominant Parkinson's Disease (TDPD) in…
  • 2025 International Congress

    DBS Withdrawal Syndrome in Advanced Parkinson’s Disease: A Case Series

    H. Omercikoglu Ozden, S. Irmak, D. Gunal (İstanbul, Turkey)

    Objective: Deep Brain Stimulation (DBS) is a widely used neuromodulation therapy for managing motor complications in advanced Parkinson’s disease (PD). However, abrupt cessation of DBS,…
  • 2025 International Congress

    Stimulation-Entrained Gamma-Driven Adaptive DBS Improves Motor Diary Reports of Symptom Fluctuations in Parkinson’s Disease

    L. Hammer, S. Cernera, C. Oehrn, M. Shcherbakova, A. Hahn, J. Yao, O. Weiss, S. Little, P. Starr (Philadelphia, USA)

    Objective: To compare adaptive deep brain stimulation (aDBS) using stimulation-entrained gamma oscillations as a feedback signal to conventional constant-amplitude deep brain stimulation (cDBS) using validated…
  • 2025 International Congress

    Distinguishing DBS and Non-DBS Parkinson’s Patients Using Recurrence Plots and Vision Transformers

    V. Skaramagkas, G. Karamanis, I. Boura, C. Chatzaki, I. Kyprakis, D. Fotiadis, C. Spanaki, Z. Kefalopoulou, M. Tsiknakis (Estavromenos, Heraklion, Greece)

    Objective: To introduce an innovative method for distinguishing gait patterns in Parkinson’s Disease (PD) patients with medical or surgical treatment and healthy controls, by exploiting…
  • 2025 International Congress

    Novel Technologies for REM Sleep Behavior Disorder Detection to Identify Prodromal Parkinson’s Disease at Home

    K. Colman, F. Dijkstra, D. Crosiers, I. de Volder, J. Verbraecken, AM. Schyvens, M. Viaene, O. Wolfgang, A. Pijpers (Edegem, Belgium)

    Objective: Isolated REM sleep behavior disorder (RBD) is a strong prodromal marker of Parkinson’s disease (PD) and related alpha-synucleinopathies. Early identification is crucial for timely…
  • 2025 International Congress

    The effect of continuous subcutaneous foslevodopa/foscarbidopa infusion on sleep in Parkinson’s disease: three case reports

    H. Sakuramoto, H. Fujita, K. Suzuki (Shimotuga Mibu, Japan)

    Objective: To assess the effect of continuous subcutaneous infusion of foslevodopa/foscarbidopa (LDP/CDP) on sleep in a patient with Parkinson’s disease (PD). Background: Continuous subcutaneous infusion…
  • « Previous Page
  • 1
  • …
  • 54
  • 55
  • 56
  • 57
  • 58
  • …
  • 181
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley